With COVID-19 dominating the science industry for the last year, our mission to #SupportScience has never been more important. Let’s take a look at some of this month’s key findings.
CondoCell® eliminates the harmful effects cells currently experience within the most in vitro tools by delivering stable, uninterrupted control over the growth conditions they require.
Visit the CondoCell® webpage!
Scientists at Huazhong University of Science and Technology have recently developed a nanophotosynthetic therapy platform that they hope could eventually protect against brain damage in stroke patients.
The SCI-tive range of advanced O2 controlled workstations are designed to mimic in vivo conditions, providing a continuous cell culture environment.
Scientists at The University of New South Wales have discovered that in order to fight pancreatic cancer more effectively, cancer cells and their collaborators need to be attacked.
By widening the fight to include CAF’s, scientists might finally be able to overcome the disease.
To support them in providing the highest quality of sterile products for patient care, Baker recently partnered with QuVa Pharma who will providing new laboratory space and clean rooms in their new facility in Bloomsbury, NJ.
A study has shown that low doses of radiation could help to improve the quality of life for patients living with Alzheimer’s disease.
Further studies are now underway to determine the optimal range and efficacy.
Did you know that in 1951, Baker designed and built the first clean air work station?
From here, Baker worked to set many industry standards for quality, performance and construction.
Sign up to our monthly newsletter to stay up to date on everything that’s going on at Baker.